Search This Blog

Wednesday, May 8, 2019

Inogen downgraded to Neutral from Overweight at JPMorgan

JPMorgan analyst Robert Marcus downgraded Inogen to Neutral from Overweight and cut his price target for the shares to $72 from $175.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.